Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1807512-39-5
2055016-25-4
1446282-44-5
254762-10-2
750541-89-0
96962-42-4
1464091-56-2 | tert-Butyl 3-(2-aminophenoxy)piperidine-1-carboxylate | AA00HXF2 | MFCD09953038
1496108-57-6 | 1-(5-Bromopyridin-2-yl)-5-cyclopropyl-1h-pyrazole-4-carboxylic acid | AA00HXND | MFCD20997467
1523541-82-3 | (2R,4R)-4-Fluoropyrrolidine-2-carboxylic acid hydrochloride | AA00HXWM | MFCD27986959
153652-70-1 | (4S,5R)-3-Benzoyl-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid | AA00HY2R | MFCD11046552
156-81-0 | 2,4-Diaminopyrimidine | AA00HYA7 | MFCD00038023
159954-28-6 | 6-Chloro-1H-indol-3-yl-beta-D-glucopyranoside | AA00HYHW | MFCD00467206
16260-24-5 | Tetraphenethyl-stannane | AA00HYP0
16423-68-0 | Erythrosin B, soldium salt | AA00HZ0B | MFCD00144257
1698-60-8 | Chloridazon | AA00HZ9K | MFCD02668021
1721-93-3 | 1-Methylisoquinoline | AA00HZHL | MFCD00006902